HomeIndustriesHealthcareEli Lilly (LLY) Hits Highs After FDA Approves Its Alzheimer’s Treatment

Eli Lilly (LLY) Hits Highs After FDA Approves Its Alzheimer’s Treatment

Eli Lilly (LLY) hit a new all-time high today as the FDA approved its Alzheimer’s treatment “Kisunla.” The treatment is intended for adults in early symptomatic stages of Alzheimer’s disease.

Morning Trade Live

03 Jul 2024

SHARE

ON AIR
12:30 am
Market On Close
replay
12:00 am
Market Overtime
REPLAY
ON AIR
12:30 am
Market On Close
REPLAY
education
2:00 am
Your First Trade
REPLAY
education
2:30 am
Your First Trade
REPLAY
3:00 am
Fast Market
REPLAY
4:00 am
Next Gen Investing
REPLAY
education
5:00 am
Liz Ann Live
REPLAY
5:30 am
The Wrap
REPLAY
7:00 am
Market Overtime
REPLAY
8:00 am
Market Overtime
REPLAY
8:30 am
Market On Close
REPLAY
education
10:00 am
Schwab 2026 Outlook
REPLAY
11:00 am
Fast Market
REPLAY
12:00 pm
Next Gen Investing
REPLAY
education
1:00 pm
Liz Ann Live
REPLAY
1:30 pm
The Wrap
REPLAY
3:00 pm
Market Overtime
REPLAY
4:00 pm
Market Overtime
REPLAY
4:30 pm
Market On Close
REPLAY
education
6:00 pm
Schwab 2026 Outlook
REPLAY
7:00 pm
Fast Market
REPLAY
8:00 pm
Next Gen Investing
REPLAY
education
9:00 pm
Liz Ann Live
REPLAY
9:30 pm
The Wrap
REPLAY
11:00 pm
Market Overtime
REPLAY

Schwab Network's Newsletters

Daily insights for every investor